BioAge Labs
4 known investors
BIOAGE develops therapies targeting the molecular pathways that drive aging to increase healthspan and address age-related chronic diseases. The company uses data-driven approaches and bioinformatics to identify and develop its pipeline of aging-focused therapeutics.
Founders & leadership
KF
Kristen Fortney, PhDCo-Founder, CEO
EM
Eric Morgen, MDCo-Founder, COO
Investors · 4
In the news
- Longevity Biotech Market: 35 Funding Deals (Full List 2024-2026) (2026) – New Market Pitchnewmarketpitch.com · 2026
- Top Longevity Biotech Startups by Fundraising (2026) – New Market Pitchnewmarketpitch.com · 2026
- Why BioAge Labs (BIOA) Is Up 6.3% After Starting QUELL-CV Phase 2 Trial For BGE-102 - Simply Wall St Newssimplywall.st · 2026
- BioAge Labs principal accounting officer sells $1.57m in stock By Investing.comca.investing.com · 2026
- BioAge Labs Secures $115 Million Series | Signalbasetrysignalbase.com · 2026
- BioAge Labs - 2026 Funding Rounds & List of Investors - Tracxntracxn.com · 2021